CLINICAL AND PATHOLOGICAL DIFFERENCES BETWEEN PRIMARY AND SECONDARY DENGUE
- Primary infection is milder in intensity and presents generally with coryza, fever, rash, body ache, joint ache and headache, chills and malaise
- Secondary infection presents a much more serious clinical course comprising Grade 3 dengue hemorrhagic fever and complications like dengue shock syndrome
- Serologically, primary infection is characterized by rise in dengue-specific IgM by 4–5 days of fever onset, followed by rise of IgG antibody with 7–10 days.
- IgM antibodies for dengue may remain elevated for 2 to 3 months after the illness.
- The diagnosis of primary dengue in the initial 5 days, therefore, requires utilization of polymerase chain reaction techniques (RT-PCR) or antigen detection, especially the NS1 antigen
- Secondary infection is recognized by an early rise in the IgG antibody titer and a lower titer of IgM rise.
- Again, early phases of secondary dengue also show PCR and NS1 positivity
Ref: Mandavdhare HS, Sharma V. Differentiating primary and secondary dengue infections: Why and how? Med J DY PatilUniv 2016;9:594-5
|IgG antibody||IgM antibody||NS1 antigen||Polymerase chain reaction|
|Early primary infection||–||–||+++||+++|
|Late primary infection||-/+||++||–||–|
|Early primary infection||++||-/+||++||+++|
|Late primary infection||++||+||–||–|
* – Likely to be negative, + Likely to positive, +/- Varibale, ++ very likely to be positive, +++ Extremely likely to be positive
Ref: Center for Disease Control and Prevention. Laboratory Guidance and Diagnostic
Testing. Available from: http://www.cdc.gov/dengue/clinicallab/laboratory.html
Cross Reactivity in Serology needs to be factored in prior to a diagnosis
- Serological cross-reactivity across the flavivirus group is common (i.e. between dengue 1, 2, 3 & 4, Japanese encephalitis, Murray Valley encephalitis, St. Louis encephalitis, West Nile, and yellow fever viruses). These diseases must be excluded before confirmation of diagnosis.
- Heterophilic antibodies are a well-recognised cause of interference in immunoassays . These antibodies to animal IgG may cross-react with reagent antibodies and generate a false positive signal. This must be excluded before confirmation of diagnosis.
- Cross reactivity is also known due to interference with antibodies against Epstein-Barr virus, Malarial parasite, Influenza A and B, Anti-nuclear antibody, Rheumatoid factor Hepatitis A, Leptospira, Salmonella typhi, Scrub typhus and West Nile virus
Ref: WHO Report: Evaluation of commercially available anti-dengue virus IgM tests.
Diagnostic evaluation series No.3
HEALTH AUTHORITIES STRONGLY DISCOURAGE RAPID DENGUE TESTS
The use of rapid tests for dengue has been discouraged by the Health Ministry of India as the rapid diagnostic kits are generating up to 50% of false ‘positives’ for dengue (Times of India report, Sep 17, 2015)
PCR OFFFERS A CLEAR ADVANTAGE OVER OTHER MODALITIES IN DIAGNOSING DENGUE
|RT – PCR||NS1||Clinical Benefit|
Additional 5-10% patients accurately detected positive by PCR
Ref: Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control:
New Edition- WHO 2009.ECDC training Workshop on laboratory diagnosis of dengue
virus infections Berlin, 23-27 January 2012. CENTER FOR DISEASE CONTROL
WHICH INFORMATION DOES THE LABORATORY NEED FOR FURTHER INTERPRETATION OF THE RESULTS?
The availability of the following data points pertaining to the Clinical and personal history of the patient could prove instrumental in corroborating the lab test results with the clinical presentation
- Date of onset of illness ( not fever alone )
- Date of sample collection
- Travel history (country, dates…)
- Other diagnosis
- Previous flavivirus infections or vaccinations
- History of previous travel to endemic areas
- Previous fever episodes after travel
- Concise clinical findings
DENGUE IS OFTEN SUBCLINICAL!
Quite a large proportion of patients who test positive for Dengue infection, do not show any symptoms.
In case of elevated IgG and IgM with no symptoms (seropositive but asymptomatic) – it could be the convalescent phase of the disease as antibodies can be found for upto 3 months after the illness
This is in fact the “Unapparent” or “Subclinical” form of Dengue which forms a large portion of the total disease burden
The WHO’s regional office for South East Asia confirms the following
There are many people who are infected with the virus and do not suffer from any signs or symptoms of the disease. For every patient with symptoms and signs, there may be four or five persons with either no symptoms or very mild symptoms.